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Differentiation of preadipocytes to adipocytes is controlled by the nuclear receptor peroxisome proliferator-
activated receptor g (PPARg), but little is known about earlier transcriptional events in mesenchymal stem
cells that define the adipocyte lineage. A recent report (Gupta et al., 2010) identifies the zinc finger protein
Zfp423 as a determining factor in preadipocyte commitment.Much of what is known about adipocyte
differentiation has been gleaned from
studies of the fibroblast cell line 3T3-L1,
which was derived from Swiss albino
mouse embryos through clonal expansion
(Green and Meuth, 1974). This adipocyte-
lineage committed clone (which is there-
fore referred to as a preadipocyte line)
readily undergoes adipocyte conversion
and lipid accumulation upon stimulation
with the hormonal inducers insulin, dexa-
methasone, and cAMP-elevating agents.
The discovery of peroxisome prolifera-
tor-activated receptor g (PPARg) as an
adipocyte-predominant transcription fac-
tor induced during 3T3-L1 differentiation
laid the foundation for our current under-
standing of the transcriptional network
leading to adipocyte differentiation from
preadipocytes (Chawla et al., 1994; Ton-
tonoz et al., 1994). CCAAT/enhancer
binding protein (C/EBP) factors b and
d are induced early in adipogenesis and
trigger the rapid increase of PPARg
expression, which, in a feed forward
loop, amplifies its own as well as C/EBPa
expression leading to terminal adipocyte
differentiation (Figure 1). Many other tran-
scription factors whose levels change
during 3T3-L1 adipogenesis have also
been found to control the capacity for
adipocyte formation (Lefterova and Lazar,
2009). These findings may ultimately be
the basis for therapeutic interventions
that address adipocyte dysfunction in
obesity and type 2 diabetes.
3T3-L1 and other adipogenic cell lines
are already committed to the adipocyte
lineage, and hence little known about the
mechanism that commits precursors to
the adipocyte fate. A recent study by
Gupta et al. (2010) used an elegant ap-
proach to identify transcriptional compo-244 Cell Metabolism 11, April 7, 2010 ª2010nents of this process. The levels of
mRNAs encoding 1800 putative tran-
scriptional regulators were measured in
clonal Swiss 3T3 sublines with markedly
different adipogenic potential, and this
screen identified a number of differentially
expressed factors, which correlate with
either high or low adipogenic capacity.
One of these, a zinc finger protein called
Zfp423, was capable of setting the stage
for adipocyte differentiation when intro-
duced into nonadipogenic fibroblasts. Of
interest, Zfp423 expression is not regu-
lated during adipocyte differentiation,
and thus it would not have been identified
by differential analysis of preadipocytes
and adipocytes in 3T3-L1 and similar
model systems. However, depletion of
Zfp423 in 3T3-L1 cells reduced basal
levels of PPARg1 and PPARg2 and im-
paired adipocyte conversion. Further-
more, the authors provide evidence that
a great number of other preadipocyte-
enriched genes identified by genome-
wide expression arrays are dependent
on Zfp423 levels, suggesting a transcrip-
tional hierarchy within this group of genes.
It is noteworthy that, in brown adipo-
cytic precursor cells, Zfp423 depletion
reduced the expression of PPARg as
well as PRDM16, a brown adipocyte
determination factor (Seale et al., 2007).
This finding could suggest that Zfp423
acts very early in the commitment phase
of mesoderm-derived cells since brown
adipocytes and muscle cells appear to
be in a Myf5+ lineage distinct from white
adipocytes (Seale et al., 2008). However,
there were no obvious defects in muscle
differentiation, which would argue against
this. Alternatively, Zfp423-dependent in-
duction of PPARg and precursor commit-
ment could be a conserved mechanism inElsevier Inc.both brown and white adipocyte cell line-
ages. Further experiments will be needed
to elucidate the exact relationship bet-
ween Zfp423 and the commitment of
Myf5+ precursor cells.
Gupta et al. also addressed the mecha-
nism by which Zfp423 induces PPARg
expression and commits fibroblasts to
the adipocyte lineage. Zfp423 had been
previously shown to bind SMAD1/
SMAD4 (Hata et al., 2000), but a Zfp423
mutant that lacks the SMAD-binding
domain was still able to induce PPARg2
and enhance adipocyte conversion,
suggesting a SMAD-independent mecha-
nism. However, an increase in BMP4-
mediated induction of PPARg2 and
adipogenesis by ectopically expressed
Zfp423 was blunted in fibroblasts ex-
pressing this mutant, underlining the im-
portance of this domain for specific
adipogenic signals. Future experiments
will be required to uncover the whole
spectrum of how Zfp423 controls the
commitment of mesenchymal stem cells
to adipogenic differentiation. Zfp423 was
originally identified as a binding partner
and negative regulator of Ebf1, a basic
helix-loop-helix transcription factor re-
quired for B cell lineage determination
and olfactory epithelium development
(Tsai and Reed, 1997), and recent reports
implicate Ebf-factors in mesenchymal cell
lineage determinations, such as adipo-
cyte and osteoblast differentiation (Aker-
blad et al., 2002; Hesslein et al., 2009).
Gupta et al. went on to investigate
the role of Zfp423 in fat cell formation
in vivo. Because mice lacking Zfp423
display developmental defects and poor
viability (Cheng et al., 2007), day 18.5
embryos were compared for the amount
of interscapular brown adipose tissue
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Figure 1. A Role for Zfp423 in Preadipocyte
Determination
(A) Zfp423 induces expression of the master regulator of
adipogenesis, PPARg, and commits cells to become prea-
dipocytes.
(B) PPARg acts in a feed forward loop with C/EBP factors
to maintain high expression of each other and to terminally
differentiate the cells into adipocytes.
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ment during this developmental
stage. Zfp423 null mice displayed a
reducedmass of BAT and an increase
in connective tissue intrusions. More-
over, developing white adipocyte
precursor cells in the subcutaneous
region were strongly reduced in
Zfp423 null mice. In accordance with
the finding that Zfp423 was not
expressed in primary or C2C12 myo-
blasts, there was no obvious defect
in other mesodermal lineages, as
muscle and connective tissues ap-
peared normal in these embryos.
Tissue-specific or cell lineage-spe-
cific Zfp423 ablation will be required
to fully understand the physiologic
role of Zfp423.
Taken together, the findings pre-
sented by Gupta and colleagues
bridge an existing gap in our under-standing of adipocyte differentiation,
which has been largely focused on the
transition from preadipocytes to adipo-
cytes using established cell lines such as
the 3T3-L1 model. In this context, the
new work implicates the zinc finger
protein Zfp423 as a key factor to explainthe critical question of howprecursor cells
become fated for fat (Figure 1).
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Nutrients such as amino acids (aa) and glucose mediate mammalian target of rapamycin complex 1
(mTORC1) signaling to control cell growth andmetabolism. Recent studies (Yan et al., 2010) identify a contrib-
utor, PP2A phosphatase subunit PR613, in regulating the aa-sensitive input to mTORC1.The epidemic in obesity and associated
pathologies, including insulin resistance,
type 2 diabetes, cardiovascular disease,
and cancer (Calle and Kaaks, 2004), has
been fueled by nutrient overload driven
by the abundance, palatability, and low
cost of food (Finkelstein et al., 2005).
The intracellular serine-threonine kinasemTOR plays a critical role in mediating
these pathologies. The rapamycins (spe-
cific mTOR inhibitors) have been ap-
proved for treatment of renal cancers
(Houghton, 2010), and recent studies
show that they increase life span, possibly
through their ability to recapitulate the
effects of caloric restriction (Katewa andKapahi, 2010). mTOR is found in two
structurally and functionally distinct com-
plexes, mTORC1 and mTORC2. Although
both complexes are implicated in hor-
monal signaling mediated by class 1
phosphatidylinositide-3OH kinase (PI3K),
only mTORC1 is positively regulated by
nutrients, particularly aa and glucose. In, April 7, 2010 ª2010 Elsevier Inc. 245
